Carasent AB (publ)APXZF 80 Market Cap is $157.05 Mil as of Jun. 29, 2026. GuruFocus rates APXZF with a GF Score™ of 80/100 and a GF Value™ of $0.18. The stock has 3 warning signs investors should review. Among 694 Healthcare Providers & Services companies, Carasent AB (publ) ranks better than 56.63% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Carasent AB (publ)'s share price for the quarter that ended in Mar. 2026 was $0.15. Carasent AB (publ)'s Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 66.85 Mil. Therefore, Carasent AB (publ)'s market cap for the quarter that ended in Mar. 2026 was $10.03 Mil.
Carasent AB (publ)'s quarterly market cap
declined
from Sep. 2025 ($10.49 Mil) to Dec. 2025 ($10.27 Mil) and
declined
from Dec. 2025 ($10.27 Mil) to Mar. 2026 ($10.03 Mil).
Carasent AB (publ)'s annual market cap
stayed the same
from Dec. 2023 ($10.85 Mil) to Dec. 2024 ($10.85 Mil) but then
declined
from Dec. 2024 ($10.85 Mil) to Dec. 2025 ($10.27 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Carasent AB (publ)'s Enterprise Value for Today is $146.68 Mil.
Carasent AB (publ) (OTCPK:APXZF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Carasent AB (publ) Market Cap Related Terms
Carasent AB (publ) Market Cap Historical Data
* Premium members only.
The historical data trend for Carasent AB (publ)'s Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Carasent AB (publ)'s Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carasent AB (publ) Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Carasent AB (publ)'s Market Cap distribution charts can be found below:
* The bar in red indicates where Carasent AB (publ)'s Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Carasent AB (publ)'s Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carasent AB (publ) (APXZF) has a Market Cap of $157.05 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Carasent AB (publ) and its competitors. According to the industry distribution chart, Carasent AB (publ) ranks #301 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 43.4%.
Is Carasent AB (publ)'s Market Cap too high?
Carasent AB (publ)'s current Market Cap is $157.05 Mil. The Healthcare Providers & Services industry median Market Cap is 93.08. Carasent AB (publ)'s value of $157.05 Mil is 68.7% above this industry median. Based on the distribution chart, Carasent AB (publ) ranks #301 out of 694 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Carasent AB (publ) has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Carasent AB (publ)'s Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Carasent AB (publ) ranks #301 out of 694 companies for Market Cap. This puts Carasent AB (publ) in the upper half of its industry. The industry median Market Cap is 93.08. Carasent AB (publ)'s value of $157.05 Mil is 68.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 93.08, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carasent AB (publ)'s current Market Cap of $157.05 Mil is 68.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Carasent AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 93.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carasent AB (publ)'s current Market Cap is $157.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carasent AB (publ) stock overvalued right now?
Carasent AB (publ) (APXZF) has a current Market Cap of $157.05 Mil. The stock's GF Value™ is $0.18, compared to a current price of $0.15 — trading 16.7% below its estimated fair value. The current Market Cap is $157.05 Mil and 68.7% above the Healthcare Providers & Services industry median of 93.08. Carasent AB (publ)'s overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Carasent AB (publ) (APXZF), the current Market Cap is $157.05 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carasent AB (publ) (APXZF) Overvalued in 2026?
Based on GuruFocus' analysis, Carasent AB (publ) stock appears to be undervalued.
The current stock price of $0.15 is trading 16.7% below its estimated GF Value™ of $0.18.
Key valuation signals for APXZF:
Market Cap: $157.05 Mil
GF Value™: $0.18 vs. price of $0.15 (16.7% below fair value)
Industry Position: 68.7% above the Healthcare Providers & Services median (#301 of 694)
No single metric tells the full story. See the APXZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carasent AB (publ) Formerly Carasent AB is a comprehensive provider of cloudbased EHR solutions and platform services for various organizations within the healthcare sector. With Webdoc as the main product, the group offers a broad ecosystem of services, including solutions for patient communication and business intelligence. Geographically, the company operates in the Nordic region and Germany. It derives maximum revenue from Nordic Region. The solutions provides by the group are: Webdoc; Metodika; Medrave; HPI plustoo; Ad Curis; Ad Opus; Webcur; Data-AL; and Data-Cur.
80GF Score
Get the complete analysis for APXZF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
APXZF has been successfully added to your 
